International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology

The recommendations that follow have been updated from the proposals of a Technical Subcommittee set up by the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification (Jenkinson DH, Barnard EA, Hoyer D, Humphrey PPA, Leff P, and Shankley NP (1995) International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol Rev 47:255–266).

[1]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[2]  J. Black,et al.  Further analysis of anomalous pKB values for histamine H2‐receptor antagonists on the mouse isolated stomach assay , 1985, British journal of pharmacology.

[3]  O. ARUNLAKSHANA,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.

[4]  J. Gaddum.  Introductory address. Part I. Biological aspects: the antagonism of drugs , 1943 .

[5]  A. Christopoulos,et al.  Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting , 2004 .

[6]  M. Lew,et al.  Analysis of competitive agonist-antagonist interactions by nonlinear regression. , 1995, Trends in pharmacological sciences.

[7]  Terrence P. Kenakin,et al.  A Pharmacologic Analysis of Drug-Receptor Interaction , 1987 .

[8]  T. Kenakin,et al.  The ligand paradox between affinity and efficacy: can you be there and not make a difference? , 2002, Trends in pharmacological sciences.

[9]  T. Kenakin,et al.  G Protein-Coupled Receptor Allosterism and Complexing , 2002, Pharmacological Reviews.

[10]  R P STEPHENSON,et al.  A MODIFICATION OF RECEPTOR THEORY , 1997, British journal of pharmacology and chemotherapy.

[11]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[12]  R. Neubig,et al.  Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s). , 2000, The Journal of pharmacology and experimental therapeutics.

[13]  H. Schild.  pA, A NEW SCALE FOR THE MEASUREMENT OF DRUG ANTAGONISM , 1997, British journal of pharmacology and chemotherapy.

[14]  Bernard Katz,et al.  Interaction at end-plate receptors between different choline derivatives , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[15]  T. Kenakin,et al.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. , 1995, Trends in pharmacological sciences.

[16]  D. Waud,et al.  Kinetic and empirical analysis of dose-response curves illustrated with a cardiac example. , 1978, Life sciences.

[17]  R. Lefkowitz,et al.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.

[18]  D. Waud.  Analysis of dose-response curves , 1981 .

[19]  S. Lazareno,et al.  Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng‐Prusoíf equations , 1993, British journal of pharmacology.

[20]  J. Black,et al.  Operational models of pharmacological agonism , 1983, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[21]  D. Colquhoun.  Affinity , Efficacy , and Receptor Classification : Is the Classical Theory Still Useful ? , 2022 .

[22]  H. Schild.  pAx and competitive drug antagonism. , 1949, British journal of pharmacology and chemotherapy.

[23]  D. Colquhoun.  Pharmacologic Analysis of Drug–Receptor Interaction (3rd edn) , 1998 .

[24]  T. Bonner,et al.  International Union of Pharmacology. XXXI. Recommendations for the Nomenclature of Multimeric G Protein-Coupled Receptors , 2002, Pharmacological Reviews.

[25]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[26]  A. Christopoulos.  Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log. , 1998, Trends in pharmacological sciences.

[27]  P. Leff,et al.  Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. , 1998, Molecular pharmacology.

[28]  I. Mills,et al.  Quantities, Units and Symbols in Physical Chemistry , 1993 .